Correspondence 0001104659-24-050063 from iBio, Inc. (IBIO)
iBio, Inc.
Date: April 22, 2024 · CIK: 0001420720 · Accession: 0001104659-24-050063
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-278729
Letter
VIA EDGAR United States Securities Division of Corporation Finance Attention: Jimmy McNamara Re: iBio, Inc. Registration Statement on Form S-3 Filed April 16, 2024 File No: 333-278729
Dear Mr. McNamara:
iBio, Inc. (the “Registrant”) hereby requests that the effective date of the above-referenced Registration Statement on Form S-3 (File No. 333-278729) (the “Registration Statement”), be accelerated by the U.S. Securities and Exchange Commission (the “Commission”) to become effective on Wednesday, April 24, 2024, at 4:00 p.m., Eastern Time, or as soon as reasonably practicable thereafter.
The Registrant understands that the Staff of the Commission will consider this request as confirmation by the Registrant that it is aware of its responsibilities under the federal securities laws as they relate to the issuance of the securities covered by the Registration Statement.
The Registrant hereby authorizes Leslie Marlow of Blank Rome LLP to orally modify or withdraw this request for acceleration. Please contact Ms. Marlow at (516) 457-4238 with any questions you may have concerning this request, and please notify Ms. Marlow when this request for acceleration has been granted.
Very truly yours,
IBIO, INC.
Show Raw Text
CORRESP
1
filename1.htm
April 22, 2024
VIA EDGAR
United States Securities
and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attention: Jimmy McNamara
Re:
iBio, Inc.
Registration Statement on Form S-3
Filed April 16, 2024
File No: 333-278729
Dear Mr. McNamara:
iBio, Inc. (the “Registrant”)
hereby requests that the effective date of the above-referenced Registration Statement on Form S-3 (File No. 333-278729) (the “Registration
Statement”), be accelerated by the U.S. Securities and Exchange Commission (the “Commission”) to become effective
on Wednesday, April 24, 2024, at 4:00 p.m., Eastern Time, or as soon as reasonably practicable thereafter.
The Registrant understands
that the Staff of the Commission will consider this request as confirmation by the Registrant that it is aware of its responsibilities
under the federal securities laws as they relate to the issuance of the securities covered by the Registration Statement.
The Registrant hereby authorizes
Leslie Marlow of Blank Rome LLP to orally modify or withdraw this request for acceleration. Please contact Ms. Marlow at (516) 457-4238
with any questions you may have concerning this request, and please notify Ms. Marlow when this request for acceleration has been granted.
Very truly yours,
IBIO, INC.
By:
/s/ Felipe Duran
Name:
Felipe Duran
Title:
Chief Financial Officer
cc: Leslie Marlow, Blank Rome LLP